Options
|
New option listings for… New option listings for March 17th include AbCellera Biologics Inc (ABCL), American Financial Trust Inc (Class A Stock) (AFIN), one (Class A Stock) (AONE), C4 Therapeutics Inc (CCCC), Coupang Inc (Class A Stock) (CPNG), Denbury Inc (DEN), DarioHealth (DRIO), Elevate (ELVT), Earthstone Energy (ESTE), Full House Resorts (FLL), Forma Therapeutics Holdings Inc (FMTX), Generation Bio Company (GBIO), Fusion Fuel Green PLC (Class A Stock) (HTOO), IRIDEX (IRIX), JMP Group (JMP), Lion Group Holding Ltd (ADS) (LGHL), Lantern Pharma Inc (LTRN), Nurix Therapeutics Inc (NRIX), Vaxcyte Inc (PCVX), PLx Pharma (PLXP), PMV Pharmaceuticals Inc (PMVP), Rodgers Silicon Valley Acquisition Corporation (RSVA), So Young International (SY), Usio Inc (USIO), and WidePoint (WYY). ShowHide Related Items >><< - 11/25/20
- WidePoint trading resumes
- 11/25/20
- WidePoint awarded U.S. Department of Homeland Security contract
- 11/25/20
- WidePoint trading halted, news pending
- 11/02/20
- WidePoint announces over $11M in TM2 contracts during Q3
- 03/16/21
- Usio selected by Community Cares Partners as payment solution
- 02/02/21
- Usio enters partnership agreement with NextChapter
- 02/01/21
- Usio reports Q4 credit card dollars processed up 17%
- 01/28/21
- Usio partners with Emphasys Software to create MyTenantPayments
- 02/16/21
- PMV Pharmaceuticals appoints Guillermina Lozano to SAB
- 11/23/20
- PMV Pharmaceuticals doses first patient in Phase 1/2 study of PC14586
- 10/13/20
- PMV Pharmaceuticals granted Fast Track Designation of PC14586
- 03/01/21
- PLx Pharma receives FDA approval of sNDAs for VAZALORE 325 mg, 81 mg
- 11/16/20
- PLx Pharma submits sNDAs for Vazalore 325 and 81 mg to FDA
- 01/06/21
- Vaxcyte announces publication of preclinical PoC data of VAX-A1
- 12/22/20
- Vaxcyte appoints Andrew Guggenhime as president
- 03/16/21
- Nurix Therapeutics announces collaboration for drugs to treat pediatric cancers
- 01/07/21
- Nurix Therapeutics expands strategic collaboration with Sanofi
- 10/26/20
- Nurix appoints Robert Tjian as chairman of Scientific Advisory Board
- 03/17/21
- Lantern Pharma files seven patent applications on anticancer agent
- 01/04/21
- Lantern Pharma launches Antibody Drug Conjugate program
- 12/17/20
- Lantern Pharma announces collaboration with Johns Hopkins on LP-184
- 10/05/20
- Lantern Pharma advances collaboration with Georgetown University for LP-184
- 03/08/21
- Lion Group to form a second SPAC company, Aquarius I Acquisition Corp.
- 03/01/21
- Lion Group announces sponsorship of SPAC company
- 02/22/21
- Lion Group announces strategic partnership with Grandshores Technology
- 01/12/21
- Lion Group to acquire 100% of Lion FinTech Group
- 02/22/21
- JMP Group falls -14.9%
- 02/22/21
- JMP Group falls -15.0%
- 02/22/21
- JMP Group falls -15.3%
- 02/19/21
- JMP Group rises 37.8%
- 03/02/21
- Topcon acquires 10.4% stake of Iridex, enters two additional agreements
- 12/22/20
- Iridex reports that MicroPulse LT included in EGS glaucoma gudelines
- 03/04/21
- Fusion Fuel announces MoU with CEEES to develop green hydrogen infrastructure
- 01/28/21
- Fusion Fuel publishes investor presentation in advance of investor day
- 01/21/21
- Fusion Fuel announces MoU with Grupo Industrial CL for feasability study
- 12/10/20
- HL Acquisitions announces closing of business combination with Fusion Fuel
- 02/18/21
- Generation Bio appoints Ron Cooper to board of directors
- 01/04/21
- Generation Bio announces two non-viral gene therapy milestone achievements
- 01/20/21
- Forma Therapeutics announces first patient dosed in FT-7051 trial
- 12/07/20
- Forma Therapeutics presents proof-of-concept data for FT-4202 at ASH
- 11/10/20
- Forma Therapeutics FT-4202 gets orphan drug designation in Europe
- 10/26/20
- Forma Tpresents data from a planned interim analysis of olutasidenib,
- 01/25/21
- Full House Resorts plans to build augmented casino, hotel in Cripple Creek
- 12/04/20
- Full House Resorts appoints Michael Hartmeier to board of directors
- 03/10/21
- Earthstone Energy reports Q4 average daily output 14.8K BOE/D vs 17.6K BOE/D y/y
- 02/02/21
- Earthstone Energy sees FY21 capital budget $90M-$100M
- 02/02/21
- Earthstone Energy sees Q4 oil and gas volumes roughly 1.4 MMBoe
- 12/18/20
- Earthstone Energy rises 14.8%
- 02/08/21
- Elevate Credit not guiding FY21 due to COVID uncertainty
- 02/08/21
- Elevate Credit board authorized $25M increase to existing share buyback program
- 10/14/20
- Elevate Credit promotes Scott Greever to chief product officer
- 01/27/21
- DarioHealth to acquire Upright Technologies for $29.5M in stock, $1.5M in cash
- 12/22/20
- DarioHealth enters into agreement with Presbyterian Medical Services
- 11/24/20
- DarioHealth to offer therapeutics solution to Fortune 500 technology companies
- 09/21/20
- DarioHealth, HMC HealthWorks announce partnership agreement
- 03/16/21
- Denbury appoints Cindy Yeilding to board of directors
- 12/29/20
- Denbury to acquire Wyoming CO2 EOR fields for $12M
- 11/16/20
- Omega takes Alphabet Class A stake, exits position in JPMorgan
- 11/04/20
- Denbury reacquires NEJD, Free State pipelines from Genesis for $92.5M
- 03/16/21
- Coupang down 5% after announcing partial early lock-up release
- 03/15/21
- Bill Ackman donates 26.5M shares of Coupang to charity
- 03/14/21
- Fly Intel: Top five weekend stock stories
- 01/19/21
- C4 Therapeutics announces FDA clearance for CFT7455 IND application
- 01/06/21
- C4 Therapeutics expects to initiate Phase 1/2 trial of CFT7455 in 1H21
- 12/17/20
- C4 Therapeutics to be added to the Russell 2000, 3000 Indexes
- 02/24/21
- Markforged to become public through $2.1B One merger agreement
AFIN American Finance Trust - 03/11/21
- Plymouth Industrial REIT announces Anthony Saladino as chief accounting officer
- 01/07/21
- American Finance Trust collects 95% of original cash rent in Q4
- 12/03/20
- American Finance Trust announces rent collection update
- 10/08/20
- American Finance Trust provides Q3 rent update
- 03/10/21
- AbCellera notes 'second positive Phase 3 trial readout' for bamlanivimab combo
- 02/11/21
- AbCellera names Ester Falconer CTO
- 02/09/21
- AbCellera's Bamlanivimab gets FDA EUA for COVID-19 treatment
- 01/27/21
- AbCellera-found antibody, bamlanivimab, to be developed with VIR-7831 for Covid
- 02/08/21 SVB Leerink
- AbCellera price target raised to $52 from $45 at SVB Leerink
- 01/26/21 Berenberg
- Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg
- 01/25/21 BMO Capital
- AbCellera price target raised to $61 from $48 at BMO Capital
- 01/05/21
- Fly Intel: Top five analyst initiations
AFIN American Finance Trust - 03/01/21 B. Riley
- American Finance Trust price target raised to $11 from $9 at B. Riley
- 11/09/20 B. Riley
- American Finance Trust price target lowered to $9 from $10 at B. Riley Securities
- 03/26/20 B. Riley
- American Finance Trust upgraded to Buy from Neutral at B. Riley FBR
- 12/08/20 BMO Capital
- C4 Therapeutics price target raised to $45 from $33 at BMO Capital
- 11/24/20 Morgan Stanley
- Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley
- 10/28/20 UBS
- C4 Therapeutics initiated with a Buy at UBS
- 10/27/20 Jefferies
- C4 Therapeutics initiated with a Buy at Jefferies
- 01/20/21 Roth Capital
- Denbury initiated with a Buy at Roth Capital
- 09/22/20 Capital One
- Denbury upgraded to Overweight from Underweight at Capital One
- 09/22/20 Capital One
- Denbury upgraded to Overweight from Equalweight at Capital One
- 09/21/20 Alliance Global Partners
- Alliance Global upgrades Evolution Petroleum on removed near-term risks
- 02/01/21 Alliance Global Partners
- DarioHealth downgraded to Neutral from Buy at Alliance Global Partners
- 08/17/20 Aegis
- DarioHealth initiated with a Buy at Aegis
- 08/13/20 Craig-Hallum
- DarioHealth price target raised to $17 from $8 at Craig-Hallum
- 06/22/20 ThinkEquity
- DarioHealth initiated with a Buy at ThinkEquity
- 04/14/20 Maxim
- LendingClub, Enova International, Elevate Credit cut to Hold at Maxim
- 04/14/20 Maxim
- Elevate Credit downgraded to Hold from Buy at Maxim
- 01/04/21 Northland
- Earthstone Energy named a Top Pick for 2021 at Northland
- 12/16/20 Wells Fargo
- Wells Fargo says Buy Marathon Oil, Sell Berry Petroleum
- 12/16/20 Wells Fargo
- Earthstone Energy upgraded to Overweight from Equal Weight at Wells Fargo
- 09/02/20 Alliance Global Partners
- Earthstone Energy assumed with a Buy at Alliance Global Partners
- 03/09/21 Macquarie
- Full House Resorts price target raised to $10 from $8 at Macquarie
- 02/18/21 Union Gaming
- Full House Resorts initiated with a Buy at Union Gaming
- 02/05/21 Macquarie
- Full House Resorts price target raised to $8 from $6 at Macquarie
- 12/02/20 Macquarie
- Full House Resorts price target raised to $5 from $4.50 at Macquarie
- 02/17/21
- Fly Intel: Top five analyst initiations
- 02/17/21 Oppenheimer
- Forma Therapeutics initiated with an Outperform at Oppenheimer
- 12/22/20 Cantor Fitzgerald
- Agios oncology deal a positive read to FT-4202 strategy, says Cantor Fitzgerald
- 12/09/20 BMO Capital
- Agios Pharmaceuticals price target lowered to $50 from $57 at BMO Capital
- 02/23/21 William Blair
- Generation Bio initiated with an Outperform at William Blair
- 02/23/21 William Blair
- Generation Bio initiated with an Outperform at William Blair
- 02/18/21 Needham
- Generation Bio initiated with a Buy at Needham
- 07/07/20 Cowen
- Generation Bio initiated with an Outperform at Cowen
- 02/22/21 Barrington
- JMP Group price target raised to $7.50 from $3.50 at Barrington
- 08/10/20 ThinkEquity
- Lantern Pharma initiated with a Buy at ThinkEquity
- 07/28/20 Colliers
- Drug 'rescuer' Lantern Pharma started at Buy at Colliers
- 07/28/20 Colliers
- Lantern Pharma initiated with a Buy at Colliers
- 02/17/21 Piper Sandler
- Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler
- 02/16/21 Piper Sandler
- Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler
- 01/29/21 JPMorgan
- Nurix Therapeutics price target raised to $56 from $34 at JPMorgan
- 07/16/20 Wells Fargo
- Sutro Biopharma initiated with an Overweight at Wells Fargo
- 07/07/20
- Fly Intel: Top five analyst initiations
- 07/07/20 BofA
- Vaxcyte initiated with a Buy at BofA
- 07/07/20 Jefferies
- Vaxcyte initiated with a Buy at Jefferies
- 03/01/21 JMP Securities
- PLx Pharma price target raised to $12 from $9 at JMP Securities
- 05/18/20 JMP Securities
- PLx Pharma resumed with an Outperform at JMP Securities
- 10/20/20 Evercore ISI
- PMV Pharmaceuticals initiated with an Outperform at Evercore ISI
- 10/20/20 BofA
- PMV Pharmaceuticals initiated with a Buy at BofA
- 10/20/20 BofA
- PMV Pharmaceuticals initiated with a Buy at BofA
- 10/20/20 Cowen
- PMV Pharmaceuticals initiated with an Outperform at Cowen
RSVA Rodgers Silicon Valley Acquisition - 03/11/21 Northland
- Rodgers Silicon Valley Acquisition initiated with an Outperform at Northland
- 04/23/20
- Fly Intel: Top five analyst initiations
- 04/23/20 Deutsche Bank
- So-Young initiated with a Buy, $16.20 target at Deutsche Bank
- 04/23/20 Deutsche Bank
- So-Young initiated with a Buy at Deutsche Bank
- 03/25/20 86 Research
- So-Young upgraded to Buy from Hold at 86 Research
- 02/16/21 Alliance Global Partners
- Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
- 08/03/20 Alliance Global Partners
- Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
- 08/03/20 Alliance Global Partners
- Usio downgraded to Neutral from Buy at Alliance Global Partners
- 05/07/20
- Fly Intel: Top five analyst initiations
- 12/01/20 B. Riley
- WidePoint price target raised to $13 from $10 at B. Riley Securities
- 11/12/20
- Usio reports Q3 EPS (6c), consensus (8c)
- 11/12/20
- Usio reports Q3 EPS (6c), consensus (8c)
- 03/03/21
- PMV Pharmaceuticals reports FY20 EPS ($2.40), consensus ($2.06)
- 11/13/20
- PMV Pharmaceuticals reports Q3 EPS ($1.46), two est. (34c)
- 03/12/21
- PLx Pharma reports Q4 EPS (87c) with items, consensus (29c)
- 02/16/21
- Nurix Therapeutics reports Q4 EPS (51c), consensus (54c)
- 10/14/20
- Nurix Therapeutics reports Q3 EPS (59c), consensus (41c)
- 03/10/21
- Lantern Pharma reports Q4 EPS (47c), consensus (45c)
- 12/15/20
- Lantern Pharma announces data that substantiates BBB for LP-184
- 01/11/21
- Iridex sees Q4 revenue $12.2M to $12.4M, consensus $9.61M
- 11/10/20
- Generation Bio reports Q3 EPS (46c), consensus (45c)
- 11/12/20
- Forma Therapeutics reports Q3 EPS (67c), consensus (68c)
- 03/08/21
- Full House Resorts reports Q4 EPS 12c, consensus 14c
- 01/25/21
- Full House Resorts sees Q4 revenue $37.8M-$38.5M, consensus $37.48M
- 11/05/20
- Full House Resorts reports Q3 EPS 28c, consensus (3c)
- 03/10/21
- Earthstone Energy reports Q4 adjusted EPS 9c, consensus 3c
- 11/04/20
- Earthstone Energy reports Q3 adjusted EPS (18c), consensus 8c
- 02/08/21
- Elevate Credit reports Q4 EPS 23c, consensus 20c
- 11/09/20
- Elevate Credit reports Q3 adjusted EPS 42c, consensus 17c
- 03/09/21
- DarioHealth reports Q4 revenue $2.08M, consensus $2.08M
- 01/27/21
- DarioHealth sees Q4 revenue $2.12M, consensus $2.15M
- 11/12/20
- DarioHealth reports Q3 EPS (71c), consensus (68c)
|